![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Hameln Rds S.r.o. Modra Sk, based in Slovakia, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Focussed on development & production of pharmaceutical products, with emphasis on all analytical & galenical development steps.
One of their significant offerings is Sufentanil, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2013-249 - Rev 02
This Chemical Type CEP, issued on May 13, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1569 associated with this CEP further emphasizes